By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dezima Pharma 

Gooimeer 2 - 35
1411 DC Naarden
      The Netherlands
Phone: 31-35-699-30-00 Fax: 31-35-699-30-01



Company News
Amgen (AMGN)'s Acquisition Of Dezima Pharma And CETP Drug Like Pfizer (PFE)'s '03 Buy Of Esperion (ESPR). Will History Repeat? 9/17/2015 7:00:10 AM
Amgen (AMGN) Scoops Up Dezima Pharma for $300 Million in Cash 9/16/2015 7:24:51 AM
Dezima Pharma's CETP Inhibitor, TA-8995, Phase IIb (TULIP) Study Results Published In The Lancet 6/3/2015 9:03:40 AM
Dezima Pharma Announces Complete Enrolment Of CETP Inhibitor TA-8995 Study In Subjects With Isolated, Elevated Lipoprotein(a) Levels 11/13/2014 10:18:04 AM
Dezima Pharma Reports Positive Results In Its Phase 2b TULIP Trial With CETP Inhibitor TA-8995 In Dyslipidemia 8/29/2014 8:59:42 AM
Dezima Pharma Extends Clinical Development Program For Its CETP Inhibitor TA-8995 7/9/2014 9:17:58 AM
Dezima Pharma Completes Patient Enrollment For TULIP Phase 2B Study With CETP Inhibitor TA-8995 1/13/2014 12:28:14 PM
Dezima Pharma Completes Patient Enrolment for TULIP Phase 2B Study With CETP Inhibitor TA-8995 1/13/2014 12:24:11 PM
Dezima Pharma Initiates Phase 2b TULIP Study on CETP Inhibitor Program DEZ-001 8/29/2013 10:24:44 AM